Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: A single centre study and review of the literature

Comparison of Pulmonary Involvement Between Patients Expressing Anti-PL-7 and Anti-Jo-1 Antibodies

“…Interstitial lung disease is the most frequent complication of anti-PL-7-related ASS, occurring in 80% of patients [6], but the features have not been fully elucidated. On the other hand, ILD in patients with anti-Jo-1 antibody has been described in detail [7][8][9]. Here, we aimed to clarify the features of ILD by comparing patients expressing anti-PL-7 and anti-Jo-1 antibodies.…”

Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort

“…or at least at diagnosis of myositis. Ingegnoli et al studied the anti-ARS autoantibodies as the strongest predictive factors in ILD [45]. Twenty-six patients, 19.55% of all MSA positive patients yielded antiMi-2 cases while fourteen cases, 10.53% of all MSA positive patients presented with anti-SRP positivity.…”

Imaging of Pulmonary Involvement in Rheumatic Disease

“…[103][104][105] The consolidation and ground-glass opacification is often admixed with traction bronchiectasis and reticulation, corresponding to a histologic pattern of OP on a background of fibrotic NSIP. 101,106,107 Indeed, the presence of predominantly basal reticulation and ground-glass opacification, traction bronchiectasis, volume loss, and scattered bronchocentric foci of consolidation may be the radiologic clue to the diagnosis of an antisynthetase syndrome. 108 Foci of the perilobular pattern, a recognized manifestation of OP, 109 also may be seen.…”